Johnson H, Drummer O H
University of Melbourne, Clinical Pharmacology & Therapeutics Unit, Austin Hospital, Heidelberg, Victoria, Australia.
Biochem Pharmacol. 1988 Mar 15;37(6):1131-6. doi: 10.1016/0006-2952(88)90521-7.
The hydrolytic cleavage of angiotensin I has been studied in homogenate preparations of rat lung and aorta using gradient elution HPLC to monitor the formation of peptide products. Fresh crude homogenate preparations produced a rapid breakdown of angiotensin I to largely unidentifiable fragment peptides. Neither His-Leu nor angiotensin II was observed in these preparations even in the presence of captopril (20 microM) and the amino-peptidase inhibitors, puromycin, amastatin and bestatin. However, in freeze-thawed homogenates, angiotensin II and His-Leu were detectable together with the tetrapeptide, angiotensin (1-4). The addition of captopril (20 microM) reduced the amount of angiotensin II produced but did not completely block its formation. Higher concentrations of captopril or the addition of enalaprilat or EDTA did not further reduce the amount of angiotensin II produced. In the presence of captopril a peptide corresponding to des-Leu(10)angiotensin I was formed in relatively large amounts (equivalent to 40% of angiotensin I catabolized). Homogenates purified by concanavalin A affinity chromatography gave a clean hydrolysis of angiotensin I to angiotensin II and His-Leu which was completely blocked by captopril. These results suggest an ACE-like activity in rat lung and aorta that is not sensitive to converting enzyme inhibitors.
利用梯度洗脱高效液相色谱法监测肽产物的形成,在大鼠肺和主动脉的匀浆制剂中研究了血管紧张素I的水解裂解。新鲜的粗匀浆制剂使血管紧张素I迅速分解为基本上无法鉴定的片段肽。即使存在卡托普利(20微摩尔)以及氨基肽酶抑制剂嘌呤霉素、抑肽酶和贝司他汀,在这些制剂中也未观察到组氨酸-亮氨酸或血管紧张素II。然而,在冻融匀浆中,可检测到血管紧张素II、组氨酸-亮氨酸以及四肽血管紧张素(1-4)。加入卡托普利(20微摩尔)可减少血管紧张素II的生成量,但并未完全阻断其形成。更高浓度的卡托普利或加入依那普利拉或乙二胺四乙酸(EDTA)并未进一步减少血管紧张素II的生成量。在卡托普利存在的情况下,形成了相对大量的对应于去亮氨酸(10)血管紧张素I的肽(相当于40%被分解代谢的血管紧张素I)。通过伴刀豆球蛋白A亲和层析纯化的匀浆使血管紧张素I干净地水解为血管紧张素II和组氨酸-亮氨酸,这被卡托普利完全阻断。这些结果表明大鼠肺和主动脉中存在一种类似血管紧张素转换酶(ACE)的活性,该活性对转换酶抑制剂不敏感。